CG Oncology, Inc. (CGON)

CG Oncology Revenue

CG Oncology had revenue of $1.08M in the quarter ending March 31, 2026, with 1,982.69% growth. This brings the company's revenue in the last twelve months to $5.07M, up 666.01% year-over-year. In the year 2025, CG Oncology had annual revenue of $4.04M with 254.70% growth.

• Revenue (ttm): $5.07M
• Revenue Growth: +666.01%
• P/S Ratio: 1,284.86
• Revenue / Employee: $35,711
• Employees: 142
• Market Cap: 6.50B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.04M	2.90M	254.70%
Dec 31, 2024	1.14M	935.00K	458.33%
Dec 31, 2023	204.00K	13.00K	6.81%
Dec 31, 2022	191.00K	-10.17M	-98.16%
Dec 31, 2021	10.36M	-	-

Data Source: S&P Global Market Intelligence Last updated: May 8, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 26, 2026

Data Sources Report a data error